Skip to main content

Published locations for Pembrolizumab plus eribulin shows activity in HR+, HER2-negative breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Pembrolizumab plus eribulin shows activity in HR+, HER2-negative breast cancer

User login

  • Reset your password
  • /content/pembrolizumab-plus-eribulin-shows-activity-hr-her2-negative-breast-cancer
  • /hematology-oncology/article/239378/breast-cancer/pembrolizumab-plus-eribulin-shows-activity-hr-her2
  • /breast-cancer-icymi/article/239378/breast-cancer/pembrolizumab-plus-eribulin-shows-activity-hr-her2